These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21729849)

  • 21. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review.
    Stuijt CC; Franssen EJ; Egberts AC; Hudson SA
    Drugs Aging; 2008; 25(11):947-54. PubMed ID: 18947262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs prescribed for patients hospitalized in a geriatric oncology unit: Potentially inappropriate medications and impact of a clinical pharmacist.
    Deliens C; Deliens G; Filleul O; Pepersack T; Awada A; Piccart M; Praet JP; Lago LD
    J Geriatr Oncol; 2016 Nov; 7(6):463-470. PubMed ID: 27238734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Computer-Based and Pharmacist-Assisted Medication Review Initiated in the Emergency Department.
    Liu YL; Chu LL; Su HC; Tsai KT; Kao PH; Chen JF; Hsieh HC; Lin HJ; Hsu CC; Huang CC
    J Am Geriatr Soc; 2019 Nov; 67(11):2298-2304. PubMed ID: 31335969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
    Tasaka CL; Burg C; VanOsdol SJ; Bekeart L; Anglemyer A; Tsourounis C; Rennke S
    Ann Pharmacother; 2014 Apr; 48(4):462-9. PubMed ID: 24473490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of pharmacy intervention on the use of proton-pump inhibitors in the hospital setting.
    Atkins R; Smith L
    Consult Pharm; 2013 Dec; 28(12):786-92. PubMed ID: 24322962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of pharmacists on ward rounds measured by the STOPP/START tool in a specialized geriatric unit.
    Mulvogue K; Roberts JA; Coombes I; Cottrell N; Kanagarajah S; Smith A
    J Clin Pharm Ther; 2017 Apr; 42(2):178-184. PubMed ID: 27981600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Pharmacist-Led Impact on Inappropriate Albumin Use and Costs in the Critically Ill.
    Buckley MS; Knutson KD; Agarwal SK; Lansburg JM; Wicks LM; Saggar RC; Richards EC; Kopp BJ; Erstad BL
    Ann Pharmacother; 2020 Feb; 54(2):105-112. PubMed ID: 31544470
    [No Abstract]   [Full Text] [Related]  

  • 29. The impact of clinical pharmacist in a cardiac-surgery intensive care unit.
    Al-Jazairi AS; Al-Agil AA; Asiri YA; Al-Kholi TA; Akhras NS; Horanieh BK
    Saudi Med J; 2008 Feb; 29(2):277-81. PubMed ID: 18246241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers.
    Grindlinger GA; Cairo SB; Duperre CB
    J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
    Kopp BJ; Mrsan M; Erstad BL; Duby JJ
    Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.
    Kucukarslan SN; Peters M; Mlynarek M; Nafziger DA
    Arch Intern Med; 2003 Sep; 163(17):2014-8. PubMed ID: 14504113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
    Saokaew S; Maphanta S; Thangsomboon P
    Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of pharmacy-supported interventions on proportion of patients receiving non-indicated acid suppressive therapy upon discharge: A systematic review and meta-analysis.
    Singh-Franco D; Mastropietro DR; Metzner M; Dressler MD; Fares A; Johnson M; De La Rosa D; Wolowich WR
    PLoS One; 2020; 15(12):e0243134. PubMed ID: 33270710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Educating junior doctors and pharmacists to reduce discharge prescribing of opioids for surgical patients: a cluster randomised controlled trial.
    Hopkins RE; Bui T; Konstantatos AH; Arnold C; Magliano DJ; Liew D; Dooley MJ
    Med J Aust; 2020 Nov; 213(9):417-423. PubMed ID: 33037644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of A Collaborative Strategy to Reduce the Inappropriate Use of Acid Suppressive Therapy in Non-Intensive Care Unit Patients.
    Belfield KD; Kuyumjian AG; Teran R; Amadi M; Blatt M; Bicking K
    Ann Pharmacother; 2017 Jul; 51(7):577-583. PubMed ID: 28622739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community pharmacists' evaluation of potentially inappropriate prescribing in older community-dwelling patients with polypharmacy: observational research based on the GheOP³S tool.
    Tommelein E; Mehuys E; Van Tongelen I; Petrovic M; Somers A; Colin P; Demarche S; Van Hees T; Christiaens T; Boussery K
    J Public Health (Oxf); 2017 Sep; 39(3):583-592. PubMed ID: 27698269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-use review program for concurrent histamine H2-receptor antagonist-sucralfate therapy.
    Kane MP; Briceland LL; Garris RE; Favreau BN
    Am J Hosp Pharm; 1990 Sep; 47(9):2007-10. PubMed ID: 1977317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center.
    Erstad BL; Camamo JM; Miller MJ; Webber AM; Fortune J
    Crit Care Med; 1997 Oct; 25(10):1678-84. PubMed ID: 9377882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.